DMRA

Damora Therapeutics, Inc.

Latest Form 4:Sale$7KbyWinslow Garrett (General Counsel) · filed Jul 8, 2026

Damora Therapeutics, Inc. (DMRA) has 2 SEC Form 4 filings (3 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 8, 2026.

  • Industry:Biotechnology
  • CEO:Jennifer A. Jarrett
  • Employees:7
  • HQ:Waltham, MA, US
  • IPO:2026-03-10

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$7K

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Market Cap

$1.9B

latest known value

Source
Winslow GarrettFirst in 6 months
Sale$7KJul 8SEC ↗

Related companies

Damora Therapeutics, Inc. is in the Healthcare sector.